(HealthDay News) — For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative primary breast cancer (BC), adding nivolumab to ...
The trial led by scientists at the Melanoma Institute of Australia has presented data that establishes that long-term disease ...
AI models can pass medical exams, read MRIs and blood tests, and provide diagnoses. But patients are urged to be cautious.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback